Loss of lysyl oxidase in adipose tissue ameliorates metabolic inflexibility induced by high‐fat diet

Authors:

Abstract
Objective: Systemic administration of β‐aminopropionitrile to inhibit lysyl oxidase (Lox) activity improves metabolism, but it exhibits a broad spectrum of effects. Clarification of the role of Lox in adipose tissue metabolism under high‐fat diet (HFD) conditions is needed.Methods: Mice with adipose tissue knockout of Lox (LoxAKO) and wild‐type mice were subjected to a 16‐week HFD regimen. A detailed evaluation encompassing adipose tissue, hepatic function, and systemic metabolism was conducted. RNA sequencing analysis was used to unravel the intricate mechanisms behind the metabolic enhancements in LoxAKO mice.Results: Compared with the control, although there was no difference in body weight, LoxAKO mice exhibited an improved metabolic phenotype, including enhanced insulin sensitivity, improved glucose tolerance, and reduced liver steatosis, along with reduced adipose tissue inflammation and fibrosis. LoxAKO mice showed increased thermogenic activity in brown adipose tissue with increased uncoupling protein 1 (UCP1) expression and oxygen consumption rate. Additionally, RNA sequencing analysis revealed that adipose deletion of Lox might facilitate the metabolic processing of glucose, branched‐chain amino acids, and fatty acids in brown adipose tissue.Conclusions: These findings indicate that adipocyte Lox deletion improves metabolic adaptability under an HFD, highlighting Lox as a promising therapeutic target for obesity‐associated metabolic disorders. image
Funding Information
  • National Natural Science Foundation of China (82070870, 81770844)

This publication has 45 references indexed in Scilit: